Stories Tagged as
U.S. officials want to end the HIV epidemic by 2030. Many stakeholders think they won’t.
The federal government’s ambitious plan to end the HIV epidemic, launched in 2019, has generated new ways to reach at-risk populations in targeted communities across the South. But health officials, advocates, and people living with HIV worry significant headwinds will keep the program from reaching its goals.
Why Tennessee is turning down millions of federal dollars for HIV prevention
State officials said they will instead use state funds they can control, including cutting out organizations tied to abortion care.
In time for National HIV Testing Day, progress made on prevention
A new recommendation makes PrEP, a drug that helps prevent the spread of HIV, free for many more Americans
The cost of preventing the spread of HIV? Upwards of $1,600 a month
President Trump is expected to call for an end to HIV transmission by 2030. The drug known as PrEP may be key.
The first HIV/AIDS drug was fast-tracked 30 years ago. Some lament that process.
It was 30 years ago this week that the Food and Drug Administration approved the first treatment for HIV/AIDS, the drug AZT. At a time when the number of AIDS-related deaths was skyrocketing, AZT was rushed into the approval process. But some of the early advocates of the drug’s fast-tracking ended up lamenting that process. […]
Complaint alleges discrimination against HIV/AIDS patients
Large insurers discourage high-cost patients, lawsuit says.
More drama in prescription drug pricing
A firm hiked the price of a drug 50-fold, and now there's new generic competition.
Striving to get to 'HIV zero'
Washington, D.C., and other cities are making inroads against spread of HIV/AIDS.
Don’t just get mad, decode the system
Using systems analysis in the fight against AIDS.
The costs of living with HIV: One man's story
How does living with a disease like HIV affect one's financial choices?